With the decoding of the human genome, researchers can now read the script in which evolution has written the program for the design and operation of the human body. A new generation of medical treatments is at hand. Researchers are developing therapies so powerful that there is now no evident obstacle to the ancient goal of conquering most major diseases. Nicholas Wade has covered the sequencing of the genome, as well as other health and science stories, for The New York Times, in the course of which he has interviewed many of the principal researchers in the field. In this book he describes what the genome means for the health of present and future generations. Someday soon physicians will have access to DNA chips that, from a drop of blood, will screen a person's genes for all the diseases to which he or she may be genetically vulnerable. From full knowledge of the instruction manual of the human body, provided by the genome, pharmaceutical companies hope to develop a new generation of sophisticated drugs; one of the first genome-derived drugs is already undergoing clinical trials. Another vital tool will be regenerative medicine, a new kind of therapy in which new organs and tissues will be grown from a patient's own cells to replace those that are old or diseased. With the help of DNA chips, medical researchers will soon be able to diagnose diseases such as cancer much more precisely and to tailor specific treatments for each patient. Individualized medicine will also become an important part of the pharmaceutical world. Many drugs will be prescribed based on information from DNA chips that identify which of a range of drugs is best for each patient, as well as which drugs are likely to cause side effects. The medicine of the post-genomic era will be customized for a patient's genetic make-up, providing treatments based on a precise understanding of the mechanism of disease. Life Script describes a future in which good health, even perfect health, may become the standard for everyone -- at every age.
"synopsis" may belong to another edition of this title.
Nicholas Wade was born in Aylesbury, England, and was educated at Eton College and at King's College, Cambridge. He was deputy editor of Nature magazine in London and then became that journal's Washington correspondent. He joined Science magazine in Washington as a reporter and later moved to The New York Times, where he has been an editorial writer, science editor and now a science reporter. He is the author or coauthor of four previous books and lives in Montclair, New Jersey.
By now a familiar name to readers of the New York Times "Science Times" section, Wade, who has written and edited books under the Times aegis, here tells the increasingly familiar tale of the biologists whose race for knowledge, wealth and scientific celebrity led to the first sequencing of the human genome. His stated aim is to describe the "dawning of the genomic revolution," which represents "a new starting point for science and medicine, with potential impact on every disease." In clean prose, an evenly paced narrative economy and a welter of carefully marshaled facts, Wade hits his mark admirably. After lucid chapters on the race itself, Wade settles into the implications of its conclusion. Through genotyping, Wade recounts, doctors will be able to match drugs to patients and isolate disease-causing variant genes. Someday, Wade surmises, the scalpel could be replaced by the use of therapeutic cells and proteins, and our life spans considerably enhanced by the careful manipulation of genes. Although he dismisses most criticism as "invocations of eugenics" or "effectively luddite," Wade warns that the true dangers of genome engineering "lie in the question of what changes should be permitted, if any, other than those directly related to health." Without dumbing down the issues or clogging them with data, Wade allows readers to ponder such questions for themselves. Agent: Peter Matson, Sterling Lord Literistic (Sept. 6)Forecast: Wade's name will be familiar to some, and reviews will make it so to others. This book may not fly off the shelves, but it may prove to be one of the more solid genomic fortune-telling books around, and should sell as such.
Copyright 2001 Cahners Business Information, Inc.
"About this title" may belong to another edition of this title.
FREE shipping within U.S.A.
Destination, rates & speedsSeller: Wonder Book, Frederick, MD, U.S.A.
Condition: Very Good. . Good dust jacket. Seller Inventory # I24D-00877
Quantity: 1 available
Seller: The Yard Sale Store, Narrowsburg, NY, U.S.A.
Hardcover. Condition: Good. Reliable library withdrawal in the hard cover. In the plastic protective covers. Card pocket pasted on the inside back cover. Scuff marks to the page edge. Good clean clear text. Useful. Seller Inventory # PBBKNov09000151
Quantity: 1 available
Seller: Persephone's Books, Gastonia, NC, U.S.A.
Hardcover. Condition: Fine. Dust Jacket Condition: Fine. First Edition. 204 pp. First printing. Seller Inventory # 024314
Quantity: 1 available
Seller: Research Ink, Takoma Park, MD, U.S.A.
Hardback. Condition: Very Good. 204 pp. dj. book. Seller Inventory # 32592
Quantity: 1 available
Seller: Research Ink, Takoma Park, MD, U.S.A.
Hardback. Condition: As new. 204 pp. dj. book. Seller Inventory # 34272
Quantity: 1 available
Seller: Bookman Orange, Orange, CA, U.S.A.
n/a. Condition: Very Good. Dust Jacket Condition: Very Good. Seller Inventory # 727408
Quantity: 1 available
Seller: Robinson Street Books, IOBA, Binghamton, NY, U.S.A.
Hardcover. Condition: Very Good. Prompt Shipment, shipped in Boxes, Tracking PROVIDEDVery good hardcover in very good dust jacket. Clean pages. Seller Inventory # ware547mm000
Quantity: 1 available